Reset filter
Keywords
Registration ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
Selected data models

You must log in to select data models for download or further analysis.

274 Search results.
Relevance Rating New first Old first

AMC-063 Enrollment Form (ENR) NCT01016730

- 6/3/15 - 1 form, 5 itemgroups, 7 items, 1 language
Itemgroups: Header Module, Inclusion Criteria, Exclusion Criteria, Consent for the Use of Future Specimens, Comments
AMC-063 Enrollment Form (ENR) NCT01016730 Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8163A333-B756-35E0-E040-BB89AD435080

Ovarian Cancer Registration SWOG S0904 NCT00872989 - Registration Worksheet Ovarian Cancer NCT00872989

- 5/20/15 - 1 form, 2 itemgroups, 6 items, 1 language
Itemgroups: SWOG Patient ID, Patient Information
Southwest Oncology Group S0904 Registration Worksheet for OPEN - Step 2 Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer NCT00872989 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7C965708-98F3-5904-E040-BB89AD432C8B

Fallopian Tube Cancer NCT00872989 Registration - Southwest Oncology Group S0904 Registration Worksheet - 2982652v1.0 - Southwest Oncology Group S0904 Registration Worksheet

- 1/9/15 - 1 form, 7 itemgroups, 17 items, 1 language
Itemgroups: SWOG Patient ID, Demographic Information, For SWOG Institutions, Patient Information, Stratification Question, Indicate how the patient answered the following questions on the consent form, Patient Eligibility
Southwest Oncology Group S0904 Registration Worksheet for OPEN Testing - Step 1 Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7C965708-991B-5904-E040-BB89AD432C8B

Multiple Myeloma and Plasma Cell Neoplasm NCT01055301 Registration - Southwest Oncology Group S0833 Registration Worksheet - 3189708v1.0 - Southwest Oncology Group S0833 Registration Worksheet

- 1/9/15 - 1 form, 7 itemgroups, 20 items, 1 language
Itemgroups: Protocol Information, SWOG PATIENT ID, DEMOGRAPHY, For SWOG Institutions:, Patient Information, Indicate how the patient answered the following questions on the consent form, Patient Eligibility
Southwest Oncology Group S0833 Registration Worksheet Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9BB380AB-89F9-FD3C-E040-BB89AD436314

Multiple Myeloma and Plasma Cell Neoplasm NCT00644228 Registration - Southwest Oncology Group S0777 Registration Worksheet - Step 1 - 2838964v1.0 - Southwest Oncology Group S0777 Registration Worksheet - Step 1

- 1/9/15 - 1 form, 9 itemgroups, 23 items, 1 language
Itemgroups: Protocol Information, SWOG Patient ID, Demographic Information, For All Institutions, For SWOG Institutions, Patient Information, Stratification Questions, Indicate how the patient answered the following questions on the consent form, Patient Eligibility
Southwest Oncology Group S0777 Registration Worksheet for OPEN - Step 1 Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=62BC6580-A0D5-914B-E040-BB89AD432984

Fallopian Tube Cancer NCT01081262 Registration - GOG-0241 Registration Form (R) - 3127136v1.0 - GOG-0241 Registration Form (R)

- 1/9/15 - 1 form, 4 itemgroups, 24 items, 1 language
Itemgroups: HEADER MODULE, TRACKING INFORMATION, DEMOGRAPHIC INFORMATION, BRIEF CLINICAL HISTORY
GOG-0241 Registration Form (R) Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8D17F7CB-7296-90BC-E040-BB89AD435566

Fallopian Tube Cancer NCT00951496 Registration - Gynecologic Oncology Group Registration Form (Form R) - 2758755v1.0 - Gynecologic Oncology Group Registration Form (Form R)

- 1/9/15 - 1 form, 4 itemgroups, 24 items, 1 language
Itemgroups: HEADER MODULE, TRACKING INFORMATION, DEMOGRAPHIC INFORMATION, BRIEF CLINICAL HISTORY
Gynecologic Oncology Group Registration Form (Form R) Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4F54A394-F161-2250-E044-0003BA3F9857

Fallopian Tube Cancer NCT00108745 Registration - Registration Form, GOG-0212, Form R - 2295804v3.0 - Registration Form, GOG-0212, Form R

- 1/9/15 - 1 form, 5 itemgroups, 27 items, 1 language
Itemgroups: HEADER MODULE, TRACKING INFORMATION, DEMOGRAPHIC INFORMATION, COMMENTS, FOOTER MODULE
Registration Form, GOG-0212, Form R Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=E747EA8B-589F-3EA8-E034-0003BA3F9857

Fallopian Tube Cancer NCT00108745 Pre-Study - Clinical Assessment Form, GOG-0212, Form DCA - 2321370v1.0 - Clinical Assessment Form, GOG-0212, Form DCA

- 1/9/15 - 1 form, 4 itemgroups, 27 items, 1 language
Itemgroups: HEADER MODULE, Non-Invasive Diagnostic Procedures, COMMENT, FOOTER MODULE
Clinical Assessment Form, GOG-0212, Form DCA Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FD0DEC56-A99D-220C-E034-0003BA3F9857

Fallopian Tube Cancer NCT00262847 Registration - GOG-0218 Registration Form - 2303844v3.0 - GOG-0218 Registration Form

- 1/9/15 - 1 form, 5 itemgroups, 27 items, 1 language
Itemgroups: HEADER MODULE, TRACKING INFORMATION, DEMOGRAPHIC INFORMATION, COMMENTS, FOOTER MODULE
GOG-0218 Registration Form Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F0E0A34C-6E2F-614E-E034-0003BA3F9857

Registration - NCI Cooperative Group Registration Form - 2263990v3.0 - NCI Cooperative Group Registration Form

- 9/17/21 - 1 form, 6 itemgroups, 37 items, 1 language
Itemgroups: Registration Header, Protocol Administration, Patient Demographics/Pre-Treatment Characteristics, Certification of Eligibility, Protocol Design, Initial Patient Consent for Specimen Use
NCI Cooperative Group Registration Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=D8879517-2F12-048F-E034-0003BA12F5E7

Lymphoma REGISTRATION SWOG S1108 NCT01466881 - REGISTRATION WORKSHEET Lymphoma NCT01466881

- 3/15/21 - 1 form, 5 itemgroups, 19 items, 1 language
Itemgroups: Protocol Information, SWOG PATIENT ID, DEMOGRAPHY, Patient Information, Consent form
SWOG S1108 REGISTRATION WORKSHEET Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma NCT01466881 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=AA4F8583-EC8E-07C8-E040-BB89AD430929

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial